Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Candesartan vs Lisinopril in Executive MCI
NCT01984164Phase 2Completed
- Sponsor
- Emory University
- Start
- Aug 2014
- Primary completion
- Dec 2018
- Modality
- Prodrugs/Conditional Activator Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of candesartan in Mild Cognitive Impairment (MCI), sponsored by Emory University. Started Aug 2014; status: completed.
02
Drugs
candesartan
03
Conditions
Mild Cognitive Impairment (MCI)
Beyond the preview
Go deeper on NCT01984164.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01984164.